[LIVE TRADE DAY] BIIB- Shares up 40% after Phase 3 Alzheimer’s Drug Success, Adds Over $10 billion in Market Cap in 1 day

Good morning, Trader! Here are our top 4 trade ideas today. These setups look primed! Be the best prepared trader on the Street!  - [Synaptogenix (SNPX)*-]( A Rare Gem Focusing On Alzheimer’s - BIIB- Shares up 40% after Phase 3 Alzheimer’s Drug Success, Adds Over $10billion in Market Cap in 1 day - SAVA, SNPX, LLY, PRTA- Alzheimer’s Names are Gapping in Sympathy with BIIB, In Play Today - AAPL- Down over 3% After It is Said That It’s Backing Off Plans to Increase Production of iPhone 14 *This is an Issuer-Paid Advertisement, See Disclosure Below  Sponsored By [Synaptogenix (SNPX)-]( A Rare Gem Focusing On Alzheimer’s All of Wall Street is buzzing today over the Alzheimer's for BIIB, and for good reason. This is a critical disease to fight and the market for treatments is enormous. This is a very niche sector and we are seeing a lot of attention to the few companies that are working on therapies for Alzheimer's. Our favorite play in this sector is [SNPX](, a clinical-stage biotech company focusing on not only stopping the harmful effects of Alzheimer’s but REVERSING these effects. Now I’m not a scientist but the results of their drug Bryostatin-1 look impressive- Here is a picture of the restorative potential of Bryostatin. Here are before and after images of regenerated synapses in the brain ([source]().   The other notable stock to consider in this sector is SAVA which has been in the news a lot lately (not always for good reasons!) Now according to Finviz [SNPX]( has a market cap of less than $50 million. Remember the company is currently in Phase 2 trials and expects Phase 2 data later this year. Right now, it is 40 times cheaper than SAVA, positive results would be a game changer for [SNPX](. We’ve already seen in SAVA what the market can do with a stock in the Alzheimer’s space!  Recently, [SNPX](President & Chief Scientific Officer Dr. Daniel Alkon appeared on the [TD Ameritrade Network]( to discuss the current business in front of 1000’s of investors. You can watch this short segment [here](. [Boardroom Investing]( has conducted an in depth research report into the company, you can access it [here.](  [ Click Here To Find Out More About the Company Working To Reverse the Effects of Alzheimers, A Multi-Billion Market Opportunity](  *This is an Issuer-Paid Advertisement, See Disclosure Below  Terminator Trades Enrollment Has Reopened, 2 days left, LIMITED SEATS Available [Terminator Trades]( is Ben Sturgill’s most POWERFUL Trading Project! After shutting it down for months from new subscribers, Ben has added a 3-day window for [LIMITED SEATS.]( Check out what Ben’s up to [HERE](. Here’s some of the trade ideas Ben’s students have been given access to: You’ve got a little over 2 days to sign up before [Terminator Trades]( goes away again for who knows how long! [Here is your direct link to Terminator Trades Access](  BIIB- Shares up over 40% after Phase 3 Alzheimer’s Drug Success, Adds Over $10 billion in Market Cap in 1 day After closing yesterday below $200, BIIB shares are trading around $290 in the pre-market after meeting its Primary Endpoint in its phase 3 trial for Lecanemab, an Alzheimer’s treatment. The company announced that its drug slowed progression of the disease. The drug has been very controversial, and there still may not be a huge impact slowing the disease, but the market clearly loves the news nonetheless.  The major levels to the upside are $300, $310 and $330. If today becomes a “sell the news” event, targets to the downside are $280, $260 and then $250. Many other Alzhermer’s names are gapping up in conjunction with BIIB. Don’t miss our expert traders in the[360 Wall Street Chat Room]( as they alert their best trade ideas in real time!  SAVA, SNPX, LLY, PRTA- Alzheimer’s Names are Gapping in Sympathy with BIIB, In Play Today The sympathy trade is a classic trading setup. When one company in a sector gets re-rated i.e. its price goes up and the company's value increases, investors begin to look at other stocks in the same sector and start to wonder whether they are also undervalued. After BIIB added over $10 billion to its market cap this morning with positive data for its Alzheimer’s drug, other companies in the sector are gapping up and in play. LLY was up over 8%, SAVA over 10%, PRTA over 36% and SNPX over 10%.  Watch these stocks today as there’s sure to be plenty of volatility and trading opportunities. [Here is your direct link to the 360 Wall Street Chat Room](  AAPL- Down over 3% After It is Said It’s Backing Off Plans to Increase Production of iPhone 14  The cash machine that is Apple has held up better than most tech stocks in this bear market. Prior to today it was only off around 15% from its highs. It is down over 3 percent today as the anticipated increase in demand for its new Iphone 14 is said to have failed to materialize and it will not be increasing production.  To the upside there is potential resistance at $148.55 and above that a gap to fill at $151.76. To the downside, there is potential support at $144 and $142. Below that the next level would be $138. [Here is your direct link to the 360 Wall Street Chat Room](  To your success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360.com](  © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, neither Sherwood Ventures, LLC (“Sherwood”) nor Ragingbull.com, LLC (“Raging Bull”) can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Sherwood nor Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at. TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. ISSUER-PAID ADVERTISEMENT. Synaptogenix, Inc. (“SNPX” or the “Company”) has paid or will pay Sherwood $30,000 USD per month for three months (the “Initial Term”) in cash, shares of restricted common stock with a value of $150,000, and warrants valued at issuance of $75,000 for marketing services including communicating to the public about the company through Sherwood’s affiliate Raging Bull, among others. This advertisement is part of those issuer-paid marketing services. The contract with SNPX automatically renews for successive one-month periods following the Initial Term (the “Renewal Term”) unless it is terminated by written notice of either party prior to the end of the previous term. During the Renewal Term, SNPX has agreed to pay Sherwood a monthly fee of $30,000 in cash, shares of restricted stock with a value of $50,000 and warrants valued at $25,000. As a result of this advertisement and other marketing efforts, Sherwood and/or Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Sherwood and Raging Bull, and any of their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) hold the securities of SNPX and, as permitted by law, may sell those shares during the course of this marketing arrangement or afterwards. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of SNPX, increased trading volume, and possibly an increased share price of the SNPX’s securities, which may or may not be temporary and decrease once the marketing arrangement has ended. DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [Manage your email subscriptions.](